Background

The Justice Department’s Drug Enforcement Administration has issued a final order establishing the initial 2016 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act as well as an assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine and phenylpropanolamine. These amounts represent those quantities of the covered substances to be manufactured in the U.S. to provide for the estimated medical, scientific, research and industrial needs of the U.S., lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine and phenylpropanolamine but do not include imports of controlled substances for use in industrial processes.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.